Platelet and Autotransfusion Device in Cardiac Surgery
Study of Platelet Count Changes During the Use of Autotransfusion Device in Cardiac Surgery
University Hospital, Strasbourg, France
100 participants
Feb 4, 2025
OBSERVATIONAL
Conditions
Summary
Cardiac surgery is a bleeding-risk surgery and frequently requires blood transfusion. Intraoperative autotransfusion devices are used to aspirate, process and retransfuse patients' blood. These devices are effective in recovering red blood cells and limiting the need for transfusion of packed red blood cells. Some devices, such as I-SEP's SAME®, can also be used to recover platelets, but their effectiveness has not yet been evaluated in real-life situations. The aim of this study is therefore to investigate the evolution of platelet counts following the use of an intraoperative recovery device in adult patients undergoing standard cardiac surgery
Eligibility
Inclusion Criteria4
- Patients over 18 years of age
- Having undergone standard cardiac surgery (excluding redux surgery, dissection, endocarditis, circulatory assist and transplants)
- Treated with an autotransfusion device during the surgery
- Subject having expressed their consent to the study
Exclusion Criteria5
- Anemia less than 7 g/dL
- Pregnant women
- Redux surgery, dissection, endocarditis, circulatory assistance, and transplants
- Contraindication to the use of an autotransfusion device
- Impossibility of giving the subject informed information
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard cardiac surgery using I-SEP and SAME™ autotransfusion device
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06629311